C152H151Cl11F5N23O6S2 — CID 163821284
1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)triazole-4-carboxylic acid;5-(4-chloro-2-propan-2-ylphenyl)isoquinoline;7-(4-chloro-2-propan-2-ylphenyl)isoquinoline;1-(4-chloro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;N-(4-chloro-2-propan-2-ylphenyl)pyrazin-2-amine;3-(4-chloro-2-propan-2-ylphenyl)pyridazine;4-(4-chloro-2-propan-2-ylphenyl)pyridazine;N-(4-chloro-2-propan-2-ylphenyl)pyrimidin-2-amine;5-(4-chloro-2-propan-2-ylphenyl)pyrimidine;4-(4-chloro-2-propan-2-ylphenyl)-1-(trifluoromethyl)pyrazole (PubChem CID 163821284) has the molecular formula C152H151Cl11F5N23O6S2 and a molecular weight of 2945.14 g/mol. Its IUPAC name is 1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)triazole-4-carboxylic acid;5-(4-chloro-2-propan-2-ylphenyl)isoquinoline;7-(4-chloro-2-propan-2-ylphenyl)isoquinoline;1-(4-chloro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;N-(4-chloro-2-propan-2-ylphenyl)pyrazin-2-amine;3-(4-chloro-2-propan-2-ylphenyl)pyridazine;4-(4-chloro-2-propan-2-ylphenyl)pyridazine;N-(4-chloro-2-propan-2-ylphenyl)pyrimidin-2-amine;5-(4-chloro-2-propan-2-ylphenyl)pyrimidine;4-(4-chloro-2-propan-2-ylphenyl)-1-(trifluoromethyl)pyrazole.
| Compound Name | 1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)triazole-4-carboxylic acid;5-(4-chloro-2-propan-2-ylphenyl)isoquinoline;7-(4-chloro-2-propan-2-ylphenyl)isoquinoline;1-(4-chloro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;N-(4-chloro-2-propan-2-ylphenyl)pyrazin-2-amine;3-(4-chloro-2-propan-2-ylphenyl)pyridazine;4-(4-chloro-2-propan-2-ylphenyl)pyridazine;N-(4-chloro-2-propan-2-ylphenyl)pyrimidin-2-amine;5-(4-chloro-2-propan-2-ylphenyl)pyrimidine;4-(4-chloro-2-propan-2-ylphenyl)-1-(trifluoromethyl)pyrazole |
|---|---|
| PubChem CID | 163821284 |
| Molecular Formula | C152H151Cl11F5N23O6S2 |
| Molecular Weight | 2945.14 g/mol |
| Exact Mass | 2937.82 |
| IUPAC Name | 1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;1-(4-chloro-3-fluoro-2-propan-2-ylphenyl)triazole-4-carboxylic acid;5-(4-chloro-2-propan-2-ylphenyl)isoquinoline;7-(4-chloro-2-propan-2-ylphenyl)isoquinoline;1-(4-chloro-2-propan-2-ylphenyl)-4-methylsulfonylpyrazole;N-(4-chloro-2-propan-2-ylphenyl)pyrazin-2-amine;3-(4-chloro-2-propan-2-ylphenyl)pyridazine;4-(4-chloro-2-propan-2-ylphenyl)pyridazine;N-(4-chloro-2-propan-2-ylphenyl)pyrimidin-2-amine;5-(4-chloro-2-propan-2-ylphenyl)pyrimidine;4-(4-chloro-2-propan-2-ylphenyl)-1-(trifluoromethyl)pyrazole |
| SMILES | CC(C)c1c(-n2cc(C(=O)O)nn2)ccc(Cl)c1F.CC(C)c1c(-n2cc(S(C)(=O)=O)cn2)ccc(Cl)c1F.CC(C)c1cc(Cl)ccc1-c1ccc2ccncc2c1.CC(C)c1cc(Cl)ccc1-c1cccc2cnccc12.CC(C)c1cc(Cl)ccc1-c1cccnn1.CC(C)c1cc(Cl)ccc1-c1ccnnc1.CC(C)c1cc(Cl)ccc1-c1cncnc1.CC(C)c1cc(Cl)ccc1-c1cnn(C(F)(F)F)c1.CC(C)c1cc(Cl)ccc1-n1cc(S(C)(=O)=O)cn1.CC(C)c1cc(Cl)ccc1Nc1cnccn1.CC(C)c1cc(Cl)ccc1Nc1ncccn1 |
| InChI | InChI=1S/2C18H16ClN.C13H12ClF3N2.C13H14ClFN2O2S.2C13H14ClN3.C13H15ClN2O2S.3C13H13ClN2.C12H11ClFN3O2/c1-12(2)18-10-16(19)5-6-17(18)14-4-3-13-7-8-20-11-15(13)9-14;1-12(2)18-10-14(19)6-7-17(18)16-5-3-4-13-11-20-9-8-15(13)16;1-8(2)12-5-10(14)3-4-11(12)9-6-18-19(7-9)13(15,16)17;1-8(2)12-11(5-4-10(14)13(12)15)17-7-9(6-16-17)20(3,18)19;1-9(2)11-8-10(14)4-5-12(11)17-13-15-6-3-7-16-13;1-9(2)11-7-10(14)3-4-12(11)17-13-8-15-5-6-16-13;1-9(2)12-6-10(14)4-5-13(12)16-8-11(7-15-16)19(3,17)18;1-9(2)13-5-11(14)3-4-12(13)10-6-15-8-16-7-10;1-9(2)13-7-11(14)3-4-12(13)10-5-6-15-16-8-10;1-9(2)12-8-10(14)5-6-11(12)13-4-3-7-15-16-13;1-6(2)10-9(4-3-7(13)11(10)14)17-5-8(12(18)19)15-16-17/h2*3-12H,1-2H3;3-8H,1-2H3;4-8H,1-3H3;3-9H,1-2H3,(H,15,16,17);3-9H,1-2H3,(H,16,17);4-9H,1-3H3;3*3-9H,1-2H3;3-6H,1-2H3,(H,18,19) |
| InChIKey | NVPXLNUBCBVTNX-UHFFFAOYSA-N |
| XLogP | 45.04 |
| TPSA | 368.49 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 199 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2945.14 |
| LogP ≤ 5 | 45.04 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 28 |